Potent and selective inhibitors of hepatitis C virus
US8859595B2 · kind B2 · utility
22Cited by
1References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 26, 2011 |
| Grant date | Oct 14, 2014 |
| Priority date | — |
| Expiry date | Aug 26, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds, compositions and methods for treating or preventing hepatitis C virus (HCV) infection in human subjects or other animal hosts. The compounds are as also pharmaceutically acceptable, salts, prodrugs, and other derivatives thereof as pharmaceutical compositions and methods for treatment or prevention of HCV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.